Company Filing History:
Years Active: 2000-2008
Title: David P. Rotella: Innovator in Pharmaceutical Chemistry
Introduction
David P. Rotella is a prominent inventor based in Newtown, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors for cGMP phosphodiesterase. With a total of 8 patents to his name, Rotella's work has had a substantial impact on therapeutic advancements.
Latest Patents
Among his latest patents, Rotella has developed quinoline inhibitors of cGMP phosphodiesterase. These compounds are particularly useful as inhibitors of cGMP PDE, especially Type 5. His innovative approach in this area showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
David P. Rotella is currently associated with Bristol-Myers Squibb Company, where he continues to push the boundaries of pharmaceutical research. His expertise in the field has led to numerous breakthroughs that are vital for the development of new treatments.
Collaborations
Throughout his career, Rotella has collaborated with notable colleagues, including John E. Macor and Yingzhi Bi. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
David P. Rotella's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the industry. His work continues to influence the development of new therapies that can improve health outcomes for many.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.